Denial of urinalysis-confirmed opioid use in prescription opioid dependence

Journal of Substance Abuse Treatment

Volumn 48, Issue 1, 2015, Pages 85-90

  Hilario, E Yvette ^a   Griffin, Margaret L ^a,b   McHugh, R Kathryn ^a,b   McDermott, Katherine A ^a   Connery, Hilary S ^a,b   Fitzmaurice, Garrett M ^a,b,c   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Addiction; Opioid use disorder; Opioids; Pain; Prescription opioid dependence; Self report; Substance use disorder; Urine screens

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; DEXTROPROPOXYPHENE; METHADONE; OPIATE; OXYCODONE;

ADULT; ARTICLE; DENIAL; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OPIATE ADDICTION; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY ANALYSIS; SELF REPORT; URINALYSIS; CLINICAL TRIAL (TOPIC); DRUG MISUSE; FEMALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; URINE;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; SELF REPORT; URINALYSIS;

EID: 84922883447     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.07.003     Document Type: Article

References (27)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th edn, revised ed.
2. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
3. Chelminski P.R., Ives T.J., Felix K.M., Prakken S.D., Miller T.M., Perhac J.S., et al. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Services Research 2005, 5(1):3.
4. Cone E.J., Preston K.L. Toxicologic aspects of heroin substitution treatment. Therapeutic Drug Monitoring 2002, 24(2):193-198.
5. Del Boca F.K., Noll J.A. Truth or consequences: The validity of self-report data in health services research on addictions. Addiction 2000, 95(Suppl 3):S347-S360.
6. Fishbain D.A., Cutler R.B., Rosomoff H.L., Rosomoff R.S. Validity of self-reported drug use in chronic pain patients. Clinical Journal of Pain 1999, 15(3):184-191.
7. Hariharan J., Lamb G.C., Neuner J.M. Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. Journal of General Internal Medicine 2007, 22(4):485-490.
8. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction 1991, 86(9):1119-1127.
9. Katz N.P., Sherburne S., Beach M., Rose R.J., Vielguth J., Bradley J., et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesthesia and Analgesia 2003, 97(4):1097-1102.
10. Magura S., Goldsmith D., Casriel C., Goldstein P.J., Lipton D.S. The validity of methadone clients' self-reported drug use. International Journal of the Addictions 1987, 22(8):727-749.
11. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992, 9(3):199-213.
12. Moore B.A., Fiellin D.A., Barry D.T., Sullivan L.E., Chawarski M.C., O'Connor P.G., et al. Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine 2007, 22(4):527-530.
13. Myrick H., Henderson S., Dansky B., Pelic C., Brady K.T. Clinical characteristics of under-reporters on urine drug screens in a cocaine treatment study. American Journal on Addictions 2002, 11(4):255-261.
14. Napper L.E., Fisher D.G., Johnson M.E., Wood M.M. The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users. Addictive Behaviors 2010, 35(4):350-354.
15. Rutherford M.J., Cacciola J.S., Alterman A.I., McKay J.R., Cook T.G. Contrasts between admitters and deniers of drug use. Journal of Substance Abuse Treatment 2000, 18(4):343-348.
16. Schuler M.S., Lechner W.V., Carter R.E., Malcolm R. Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies. Journal of Addiction Medicine 2009, 3(4):211-217.
17. Sekhon R., Aminjavahery N., Davis C.N., Roswarski M.J., Robinette C. Compliance with Opioid Treatment Guidelines for Chronic Non-Cancer Pain (CNCP) in Primary Care at a Veterans Affairs Medical Center (VAMC). Pain Medicine 2013, 14(10):1548-1556.
18. Sigmon S.C. Characterizing the emerging population of prescription opioid abusers. American Journal on Addictions 2006, 15(3):208-212.
19. Sobell L.C., Sobell M.B. Timeline follow-back: A technique for assessing self-reported alcohol consumption. Measuring alcohol consumption: Psychosocial and biochemical methods 1992, 41-72. Humana Press, Totowa, NJ. R.Z. Litten, J.P. Allen (Eds.).
20. Solbergsdottir E., Bjornsson G., Gudmundsson L.S., Tyrfingsson T., Kristinsson J. Validity of self-reports and drug use among young people seeking treatment for substance abuse or dependence. Journal of Addictive Diseases 2004, 23(1):29-38.
21. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings NSDUH Series H-46. Rockville, MD 2013.
22. Weiss R.D., Griffin M.L., Mazurick C., Berkman B., Gastfriend D.R., Frank A., et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. The American Journal of Psychiatry 2003, 160(7):1320-1325.
23. Weiss R.D., Najavits L.M., Greenfield S.F., Soto J.A., Shaw S.R., Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. The American Journal of Psychiatry 1998, 155(1):127-128.
24. Weiss R.D., Potter J.S., Fiellin D.A., Byrne M., Connery H.S., Dickinson W., et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 2011, 68(12):1238-1246.
25. Weiss R.D., Potter J.S., Provost S.E., Huang Z., Jacobs P., Hasson A., et al. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemporary Clinical Trials 2010, 31(2):189-199.
26. Wilcox C.E., Bogenschutz M.P., Nakazawa M., Woody G. Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants. Addictive Behaviors 2013, 38(10):2568-2574.
27. World Health Organization Composite International Diagnostic Interview (CIDI): Core Version 2.1 1997, World Health Organization, Geneva, Switzerland.